学术探索
学术期刊
新闻热点
数据分析
智能评审

Is advanced renal cell carcinoma becoming a chronic disease?

被引：7
作者：
Larkin, James [1 ]
Gore, Martin [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Renal Canc Unit, London SW3 6JJ, England
来源：
LANCET | 2010年 / 376卷 / 9741期
关键词：
INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; RESISTANCE;
D O I：
10.1016/S0140-6736(10)60816-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：574 / 575
页数：2
相关论文
共 13 条
[1]   Impact of anti-angiogenic treatments on metastatic renal cell carcinoma [J].
Ainsworth, Nicola L. ;
Lee, Jean S. Z. ;
Eisen, Tim .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (12) :1793-1805
[2]   Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial [J].
Escudier, Bernard ;
Pluzanska, Anna ;
Koralewski, Piotr ;
Ravaud, Alain ;
Bracarda, Sergio ;
Szczylik, Cezary ;
Chevreau, Christine ;
Filipek, Marek ;
Melichar, Bohuslav ;
Bajetta, Emilio ;
Gorbunova, Vera ;
Bay, Jacques-Olivier ;
Bodrogi, Istvan ;
Jagiello-Gruszfeld, Agnieszka ;
Moore, Nicola .
LANCET, 2007, 370 (9605) :2103-2111
[3]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[4]   Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma [J].
Feldman, Darren R. ;
Baum, Michael S. ;
Ginsberg, Michelle S. ;
Hassoun, Hani ;
Flombaum, Carlos D. ;
Velasco, Susanne ;
Fischer, Patricia ;
Ronnen, Ellen ;
Ishill, Nicole ;
Patil, Sujata ;
Motzer, Robert J. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1432-1439
[5]   Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new [J].
Furge, Kyle A. ;
MacKeigan, Jeffrey P. ;
Teh, Bin T. .
LANCET ONCOLOGY, 2010, 11 (06) :571-578
[6]   Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma [J].
Huang, Dan ;
Ding, Yan ;
Li, Yan ;
Luo, Wang-Mei ;
Zhang, Zhong-Fa ;
Snider, John ;
VandenBeldt, Kristin ;
Qian, Chao-Nan ;
Teh, Bin Tean .
CANCER RESEARCH, 2010, 70 (03) :1053-1062
[7]   Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma [J].
Hudes, Gary ;
Carducci, Michael ;
Tomczak, Piotr ;
Dutcher, Janice ;
Figlin, Robert ;
Kapoor, Anil ;
Staroslawska, Elzbieta ;
Sosman, Jeffrey ;
McDermott, David ;
Bodrogi, Istvan ;
Kovacevic, Zoran ;
Lesovoy, Vladimir ;
Schmidt-Wolf, Ingo G. H. ;
Barbarash, Olga ;
Gokmen, Erhan ;
O'Toole, Timothy ;
Lustgarten, Stephanie ;
Moore, Laurence ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2271-2281
[8]   Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial [J].
Motzer, Robert J. ;
Escudier, Bernard ;
Oudard, Stephane ;
Hutson, Thomas E. ;
Porta, Camillo ;
Bracarda, Sergio ;
Gruenwald, Viktor ;
Thompson, John A. ;
Figlin, Robert A. ;
Hollaender, Norbert ;
Urbanowitz, Gladys ;
Berg, William J. ;
Kay, Andrea ;
Lebwohl, David ;
Ravaud, Alain .
LANCET, 2008, 372 (9637) :449-456
[9]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
[10]   VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma [J].
Ravaud, A. ;
Digue, L. ;
Trufflandier, N. ;
Smith, D. .
ANNALS OF ONCOLOGY, 2010, 21 (02)
12